HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jörg König Selected Research

Peptides (Polypeptides)

9/2022Cancer-type organic anion transporting polypeptide 1B3 (Ct-OATP1B3) is localized in lysosomes and mediates resistance against kinase inhibitors.
7/2013Transporters and drug-drug interactions: important determinants of drug disposition and effects.
6/2008Interaction of oral antidiabetic drugs with hepatic uptake transporters: focus on organic anion transporting polypeptides and organic cation transporter 1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jörg König Research Topics

Disease

6Neoplasms (Cancer)
02/2023 - 06/2005
3Colorectal Neoplasms (Colorectal Cancer)
02/2023 - 01/2015
3Fatty Liver
11/2022 - 01/2020
3Breast Neoplasms (Breast Cancer)
09/2022 - 03/2011
3Insulin Resistance
07/2021 - 08/2011
3Cardiovascular Diseases (Cardiovascular Disease)
12/2014 - 06/2008
3Type 2 Diabetes Mellitus (MODY)
04/2013 - 06/2008
3Drug-Related Side Effects and Adverse Reactions
10/2011 - 02/2010
2Body Weight (Weight, Body)
08/2022 - 02/2010
2Obesity
01/2020 - 01/2017
2Non-alcoholic Fatty Liver Disease
01/2020 - 01/2017
2Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
08/2012 - 11/2003
1Disease Susceptibility (Diathesis)
10/2023
1Atrial Fibrillation
08/2022
1Astigmatism
01/2022
1Epilepsy (Aura)
01/2022
1Pre-Eclampsia (Preeclampsia)
01/2022
1Brain Diseases (Brain Disorder)
01/2022
1COVID-19
03/2021
1Metabolic Diseases (Metabolic Disease)
01/2020
1Lung Neoplasms (Lung Cancer)
01/2015
1Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2015
1Melanoma (Melanoma, Malignant)
01/2015
1Hematologic Neoplasms (Hematological Malignancy)
01/2015
1Carcinoma (Carcinomatosis)
01/2015
1Sarcoma (Soft Tissue Sarcoma)
01/2015
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2015
1Multiple Myeloma
01/2015
1Sclerosing Cholangitis
08/2012
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
06/2011
1Glaucoma
05/2010
1Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
01/2006
1Glioma (Gliomas)
12/2005
1Pancreatic Neoplasms (Pancreatic Cancer)
06/2005
1Liver Diseases (Liver Disease)
11/2003

Drug/Important Bio-Agent (IBA)

7Proteins (Proteins, Gene)FDA Link
02/2023 - 06/2005
3Peptides (Polypeptides)IBA
09/2022 - 06/2008
3AnionsIBA
09/2022 - 12/2005
3citrate-binding transport proteinIBA
01/2022 - 01/2017
3Organic Anion TransportersIBA
07/2013 - 04/2003
3Hypoglycemic Agents (Hypoglycemics)IBA
04/2013 - 06/2008
2Carrier Proteins (Binding Protein)IBA
10/2023 - 04/2003
2Insulin (Novolin)FDA Link
08/2022 - 01/2017
2SodiumIBA
01/2022 - 01/2020
2LipidsIBA
07/2021 - 01/2021
2CationsIBA
01/2015 - 06/2008
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
10/2011 - 06/2008
2Messenger RNA (mRNA)IBA
03/2011 - 06/2005
2Adenosine Triphosphate (ATP)IBA
01/2006 - 12/2005
2Membrane Transport Proteins (Biological Pump)IBA
12/2005 - 11/2003
1LuciferasesIBA
02/2023
1DNA (Deoxyribonucleic Acid)IBA
02/2023
1Thyroid HormonesIBA
11/2022
1Triglycerides (Triacylglycerol)IBA
11/2022
1Phosphotransferases (Kinase)IBA
09/2022
1VemurafenibIBA
09/2022
1encorafenibIBA
09/2022
1Sulfobromophthalein (Sulfobromophthalein Sodium)IBA
09/2022
1Blood Glucose (Blood Sugar)IBA
08/2022
1Citric Acid (Citrate)FDA LinkGeneric
08/2022
1Glucose (Dextrose)FDA LinkGeneric
08/2022
1dofetilide (Tikosyn)FDA Link
08/2022
1PotassiumIBA
08/2022
1Carbamazepine (Tegretol)FDA LinkGeneric
01/2022
1Pravastatin (Pravachol)FDA LinkGeneric
01/2022
1remdesivirIBA
03/2021
1Lactic Acid (Lactate)FDA LinkGeneric
01/2021
1DiglyceridesIBA
01/2021
1Cytotoxins (Cytolysins)IBA
01/2015
1Bendamustine HydrochlorideFDA Link
01/2015
1Gentian Violet (Violet, Crystal)FDA Link
01/2015
1EstersIBA
01/2015
1Alkylating AgentsIBA
01/2015
1Arginine (L-Arginine)FDA Link
12/2014
1XenobioticsIBA
07/2013
1Organic Cation Transporter 2IBA
07/2013
1Member 1 Subfamily B ATP Binding Cassette TransporterIBA
07/2013
1AcidsIBA
08/2012
1Ursodeoxycholic Acid (Urso)FDA LinkGeneric
08/2012
1Therapeutic UsesIBA
06/2011
1Mesalamine (Mesalazine)FDA LinkGeneric
06/2011
1Hormones (Hormone)IBA
03/2011
1Antineoplastic Agents (Antineoplastics)IBA
03/2011
1Estrogens (Estrogen)FDA Link
03/2011
1ProstaglandinsIBA
05/2010
1Latanoprost (Xalatan)FDA Link
05/2010
1DiureticsIBA
02/2010
1Torsemide (Demadex)FDA LinkGeneric
02/2010
1ATP-Binding Cassette Transporters (ABC Transporters)IBA
01/2006
1Phenobarbital (Luminal)FDA Link
12/2005
1multidrug resistance-associated protein 1IBA
06/2005
1Subfamily B ATP Binding Cassette TransporterIBA
11/2003
1radixinIBA
11/2003
1Tumor Biomarkers (Tumor Markers)IBA
04/2003
1ParaffinIBA
04/2003

Therapy/Procedure

1Lasers (Laser)
01/2022
1Caloric Restriction
01/2017
1Diet Therapy (Therapy, Diet)
08/2011
1Transplantation
12/2010
1Drug Therapy (Chemotherapy)
06/2005